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Protein and membrane trafficking pathways are critical for cell and tissue homeostasis. Traditional genetic and biochemical
approaches have shed light on basic principles underlying these processes. However, the list of factors required for secretory
pathway function remains incomplete, and mechanisms involved in their adaptation poorly understood. Here, we present a
powerful strategy based on a pooled genome-wide CRISPRi screen that allowed the identification of new factors involved in
protein transport. Two newly identified factors, TTC17 and CCDC157, localized along the secretory pathway and were found to
interact with resident proteins of ER-Golgi membranes. In addition, we uncovered that upon TTC17 knockdown, the polarized
organization of Golgi cisternae was altered, creating glycosylation defects, and that CCDC157 is an important factor for the
fusion of transport carriers to Golgi membranes. In conclusion, our work identified and characterized new actors in the
mechanisms of protein transport and secretion and opens stimulating perspectives for the use of our platform in
physiological and pathological contexts.
Introduction
The molecular machinery underlying the processes of pro-
tein transport and secretion has been conserved from yeast to
mammalian cells, being essential to maintain specificity and
communication between organelles, exocytosis, and endo-
cytosis. Fully one third of proteins navigate the secretory
pathway, entering this system via the ER. They are then
transported via cellular compartments, including the Golgi
apparatus and transport carriers, to be targeted to their final
destination (Lee et al., 2004). Recent demonstrations indicate
that cell compartments establish cross-regulatory mecha-
nisms through numerous membrane contact sites (Wu et al.,
2018), are endowed with tightly regulated dynamics (Valm
et al., 2017), and stand at the crossroad of signaling pathways
where inputs and outputs are integrated and coordinated
(Luini and Parashuraman, 2016). Thus, protein transport and
secretion processes are clearly more complex than previously
thought.
Yeast genetic studies and in vitro biochemical approaches
were initially used to discover the basal protein transport ma-
chinery (Novick et al., 1980; Braell et al., 1984). More recently,
arrayed RNA interference screens at the genome scale or tar-
geting kinases/phosphatases expanded the list of functional and
regulatory components of secretory pathways in metazoan cells
(Bard et al., 2006; Asensio et al., 2010; Wendler et al., 2010; Chia
et al., 2012; Simpson et al., 2012). In these studies, artificial
secreted reporters preceded by a signal sequence such as HRP
(ss-HRP) or firefly luciferase were used for detection (Bard et al.,
2006; Wendler et al., 2010). Alternatively, secretory pathway
organization or transport to the cell surface of fluorescently la-
beled exogenous transmembrane proteins such as vesicular
stomatitis virus G (VSV-G) were analyzed using high throughput
imaging or flow cytometry systems (Asensio et al., 2010; Chia
et al., 2012; Simpson et al., 2012). Although these approaches
were useful, their implementations in different cell types, with
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various cargo proteins and environmental conditions, remain
difficult.
Indeed, a current challenge is to understand how secretory
pathways are adapted and regulated in response to intrinsic
demands or environmental cues, and eventually altered in dis-
eases. Toward this objective, versatile platforms are needed to
uncover factors involved in protein transport in various physi-
ological and pathophysiological contexts. Recent developments
of the bacterial CRISPR-associated nuclease Cas9 technology
paired with libraries of single-guide RNAs (sgRNAs) have been
successfully used to perform pooled genome-wide screening
(Shalem et al., 2015; Kampmann, 2018), where targeted genes
can be disrupted (Shalem et al., 2014) and gene expression can
be inhibited or activated (Gilbert et al., 2014).
Here, we developed an efficient strategy using a pooled
genome-wide CRISPR interference (CRISPRi) screen to identify
genes involved in protein trafficking and secretion in mamma-
lian cells, and we highlight the contribution of newly identified
factors in these processes.
Results
Dual fluorescent reporter for protein transport
We first established a HeLa cell line stably expressing the
GFP-tagged TAC protein (interleukin-2 receptor) and the
catalytically inactive Cas9 (dCas9) fused to the KRAB repres-
sor protein (HeLa TAC-GFP dCas9-KRAB cells). The TAC
protein, which contains a single transmembrane domain
(TMD) and localizes at the cell surface, represents a straight-
forward reporter to investigate protein transport along the ER-
Golgi secretory pathway (Stanley and Lacy, 2010). A GFP
signal allows monitoring of the total expression of the TAC
protein, whereas its cell surface expression can be assessed by
immunofluorescence microscopy and flow cytometry analysis
using a phycoerythrin (PE)–conjugated antibody, which rec-
ognizes the extracellular domain of the TAC protein (Fig. 1,
A–C; and Fig. S1). On the other hand, the dCas9-KRAB fusion
protein in association to sgRNA targeting the transcription
start site (TSS) of specific genes (CRISPRi system) is a pow-
erful tool to inhibit gene expression (Gilbert et al., 2013). We
first tested our reporter system by incubating cells with bre-
feldin A (BFA), an inhibitor of protein transport through the
ER and Golgi membranes (Misumi et al., 1986). Flow cytometry
analysis demonstrated a decrease of TAC surface expression
upon BFA treatment (Fig. 1 D). Incubation of cells with trypsin,
a protease that cleaves most proteins expressed at the cell
surface, strongly reduced TAC surface expression that recov-
ered after 18 h in trypsin-free medium. In these conditions,
BFA treatment prevented TAC surface expression recovery
(Fig. 1 E).
We then validated our cell line by analyzing TAC expression
after knockdown of genes essential for secretory pathway
function. Cells were infected with lentivirus to express control
sgRNA (Gal4) or sgRNAs targeting the TSS of SCFD1, which
regulates SNARE complex assembly (Carr and Rizo, 2010),
Sec24A, a COPII vesicular coat subunit (Wendeler et al., 2007),
or Sec61A, which promotes translocation of secreted and
membrane proteins into the ER (Voorhees and Hegde, 2016). A
tight quality control is associated with the cotranslational in-
sertion of nascent polypeptide chains upon emergence from the
ribosomal exit tunnel, and a translocation defect of nascent
polypeptide chains in the ER leads to their degradation
(Brandman and Hegde, 2016). For this reason, down-regulation
of Sec61A is an appropriate control to monitor TAC expression
when TAC translation is altered. 7 d after infection, total and
surface TAC expressions were monitored by flow cytometry.
Sec61A knockdown, as expected, reduced both surface and total
TAC expression. However, SCFD1 and Sec24A knockdown
strongly reduced TAC surface transport without affecting the
total TAC expression (Fig. 1, F and G). Cells were also analyzed
for the surface/total TAC expression ratio. Upon SCFD1 and
Sec24A knockdown, a strong enrichment in the lower quartile
was observed related to a decrease of TAC surface expression.
Interestingly, no enrichment in one or the other quartile was
detected in Sec61A-depleted cells, where both surface and total
TAC expression were reduced (Fig. 1, G and H). Altogether,
these results established our cell line as an efficient and specific
cellular platform to monitor secretory pathway function,
and prompted us to use it to perform a pooled genome-wide
CRISPRi screen.
Genome-wide CRISPRi screen mostly identifies genes involved
in protein transport
HeLa TAC-GFP dCas9-KRAB cells were transduced with the
CRISPRi-v2 library (Horlbeck et al., 2016a) at a low MOI (0.3)
and selected for stable integration with puromycin. 7 d after
transduction, cells were separated by FACS into a high and low
surface/total TAC expression ratio, selecting upper and lower
quartiles, respectively. Genomic DNA was then isolated, and
read counts of sgRNAs were obtained by deep sequencing to
determine the abundance of each sgRNA in the two cell fractions
(Fig. 2 A). Subsequent analysis using MAGeCK (Li et al., 2014)
allowed the identification of many genes whose down-
regulation modified TAC transport at the cell surface (Table S1
and Fig. 2 B).
On one hand, in the lower quartile, gene ontology term en-
richment analysis of the 100 top-ranked genes revealed that
knockdown of genes encoding components of “Golgi vesicle
transport” was the main functional category inhibiting TAC
transport (Fig. 2, B and C). Genes involved in “toxin transport,”
“antigen processing and presentation,” and “Golgi organization”
were also highly enriched.More specifically, we identified as top
hits most of the COPI subunits (COPA, COPB1, COPB2, COPG1,
COPZ1, and ARCN1) as well as the COPII subunits Sec24A,
Sec24B, and Sec13. We also identified the SNARE Sec22B and the
SNARE-associated factors SCFD1 and NBAS, several subunits of
the TRAPP complex and the conserved oligomeric Golgi com-
plex, the small GTPase SAR1 and the Rab GTPase RAB1A, the
Sec23-interacting protein Sec23IP, and the exocyst complex
component EXOC2, among others (Table S1 and Fig. 2 B). In-
terestingly, factors belonging to small ADP-ribosylation factor
(ARF) and ADP-ribosylation factor-like (ARL) GTPases, Golgins,
or additional SNAREs were not identified among the top hits.
This is consistent with previous reports (Wendler et al., 2010;
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Simpson et al., 2012), highlighting the high degree of redun-
dancy between paralog genes that could explain why the
knockdown of these components did not alter robustly TAC
transport. Of note, genes involved in mRNA homeostasis and
protein translation were also identified among hit genes. Al-
though it is likely that their knockdown indirectly alters TAC
Figure 1. Dual fluorescent reporter for protein transport. (A) Schematic representation of the reporter based on HeLa TAC-GFP cells. (B and C) Surface
and total TAC expressions in HeLa TAC-GFP cells were analyzed by flow cytometry (B) and immunofluorescence microscopy (C). Nuclei were stained with
DAPI. Scale bars, 50 µm. (D)HeLa TAC-GFP cells were incubated in presence of 500 ng/ml BFA for the indicated times, after which cells were washed with PBS
and detached by incubation in PBS containing 0.5 mM EDTA, and surface and total TAC expressions were analyzed by flow cytometry. (E) HeLa TAC-GFP cells
were detached after incubation with 0.5 mM EDTA (Control, Ctr [i]) or with trypsin (Try [ii]), and then cells were plated in complete medium in the absence (iii)
or presence (iv) of 500 ng/ml BFA. At indicated times, surface and total TAC expressions were analyzed by flow cytometry. In D and E, surface TAC expression
was calculated relative to the total expression as the ratio of the mean of fluorescence intensities and normalized to control sample (mean of n = 3 ± SEM).
(F) HeLa TAC-GFP dCas9-KRAB cells were infected with lentivirus to express control sgRNA (Gal4) or sgRNAs targeting the TSS of SCFD1, Sec24A, and Sec61A.
7 d after infection, the knockdown efficiency of targeted genes was monitored by RT-PCR. (G) Surface and total TAC expressions (top panels) and surface/total
TAC expression ratio (bottom panels) were analyzed by flow cytometry in control HeLa TAC-GFP dCas9-KRAB cells and in cells depleted for Sec61A, SCFD1, or
Sec24A. In bottom panels, lower and upper quartiles are set on control cells and applied to the other experimental conditions. (H) Quantification of the
enrichment of cells in the lower quartile compared with the upper quartile as presented in G, bottom panels (mean of n = 4 ± SEM; two-tailed Student’s t test
for comparison to control condition sgGal4; **, P < 0.01; ns, statistically nonsignificant).
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transport, a subset of themmay also be part of transcriptional or
translational programs required for the expression of compo-
nents specifically involved in the secretory pathway. We can
also not exclude the possibility that some of these genes may
have additional nonbiosynthetic functions.
On the other hand, in the upper quartile, the knockdown of
genes encoding known components involved in “protein exit
from the ER,” “response to topologically incorrect protein,” “ER
to cytosol transport,” and “response to ER stress,” as well as
components involved in posttranslational modification, were
the main functional categories promoting TAC transport (Fig. 2,
B and D). This suggests that inhibition of themachinery required
for the maintenance of ER homeostasis and quality control along
the secretory pathway may favor transport of cargo proteins
that are most likely misfolded or incompletely processed.
Altogether, these results clearly demonstrated the value of
our approach to identify genes involved in secretory pathway
function and organization.
Figure 2. Pooled genome-wide CRISPRi screen for protein transport. (A) Schematic representation of the pooled CRISPRi screening workflow. HeLa TAC-
GFP dCas9-KRAB cells (1) were infected with the CRISPRi-v2 library (2). Then, using flow cytometry–based sorting, two cell fractions representing a low and
high surface/total TAC expression ratio were collected (3), and the abundance of each sgRNA in the two fractions was assessed by sequencing (4). The scatter
plot represents the sgRNA read counts (log2) derived from each cell fraction obtained after DNA sequencing. The color bar indicates the values of phenotype
(fold change [log2]) obtained for each individual sgRNA. sgRNAs with a phenotype <0 indicate an enrichment in the lower quartile, and sgRNAs with a
phenotype >0 indicate an enrichment in the upper quartile. (B) Volcano plot showing for each gene, the knockdown effect on TAC transport, and P value
(−log10) of phenotype. Screen replicates were averaged. Each gene targeted by the library of sgRNA is indicated with a black dot. Genes included in the 100 top
ranked genes (inserts) and belonging to functional categories of interest (highlighted in C and D) are indicated with red dots for genes inhibiting TAC transport
and with blue dots for genes stimulating TAC transport. Entire datasets are reported in Table S1. (C and D) gene ontology (GO) term enrichment analysis
among the 100 top ranked genes whose depletion results in TAC transport inhibition (C) and TAC transport stimulation (D).
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A secondary screen identifies new factors required for protein
transport and secretion
62 genes with unknown or poorly characterized function that
were identified either in the lower or upper quartiles as candi-
date genes (Table S2) were selected for a secondary screen using
a secretion assay based on the detection of ss-HRP (von Blume
et al., 2009; see Materials and methods for selection criteria of
candidate genes). Genes were knocked down in HeLa–ss-HRP
after transfection of specific smart pool siRNAs prearrayed in
a 96-well plate. After 3 d, cells were washed and incubated with
complete medium, and cell lysates and medium were harvested
after 8 h for HRP quantification. As a positive control, in SCFD1-
depleted cells, a strong signal in the cell lysate associated with a
low signal detected in themedium demonstrated a clear defect of
HRP secretion resulting in its accumulation inside cells (Fig. 3 A
and Table S2). This approach identified several genes for which
the knockdown inhibited HRP secretion. They included, for
example, WDR7, YPEL5, TMEM161, FAM162B, and GPR162 that
encode an orphan G protein coupled receptor (GPCR). Interest-
ingly, we also identified few genes where the knockdown pro-
moted HRP secretion such as TMEM167A, FAM46A, as well as the
ubiquitin specific peptidaseUSP32 (Fig. 3 A and Table S2). Future
analyses will help to dissect their roles.
We selected four genes for further analysis that encode the
coiled-coil domain-containing protein 151 (CCDC151), CCDC157,
C10orf88, and the tetratricopeptide repeat protein 17 (TTC17).
They were highly enriched in the lower quartile of the CRISPRi
screen, their knockdown strongly inhibited HRP secretion, and
they encode proteins with a poorly defined or unknown func-
tion. First, we aimed to confirm the effect of their knockdown on
TAC protein transport. HeLa TAC-GFP cells were transfected
with specific individual siRNAs and, after 3 d, knockdown effi-
ciency was monitored by RT-PCR (Fig. 3 B). Flow cytometry
analysis revealed that knockdown of the selected genes inhibited
TAC expression at the cell surface, confirming that they were
true hits (Fig. 3, C and D). We also found that their siRNA-
mediated knockdown reduced the transport of the major histo-
compatibility complex I (MHC-I), an endogenous cargo protein
trafficked along the ER-Golgi secretory pathway to the cell
surface (Fig. 3, E–G). Altogether, these results demonstrated that
the selected candidate genes were required for both exogenous
and endogenous cargo protein transport.
The newly identified factors are essential for secretory
pathway organization
Next, we assessed the role of newly identified factors on the
morphology of ER, ER exit sites, cis Golgi membranes and TGN
by immunofluorescence microscopy, using antibodies targeting
calnexin (CNX), Sec31A, GM130, and TGN46. As a control, in
SCFD1-depleted cells, Golgi membranes were completely frag-
mented, characterized by GM130- and TGN46-positive punctae
dispersed throughout the cytoplasm. Interestingly, this pheno-
type was also observed after CCDC151 and C10orf88 knockdown
(Fig. 4, A–C). Conversely, after TTC17 knockdown, Golgi mem-
branes remained localized in the perinuclear area, but presented
as an expanded structure (Fig. 4, A, B, and D). In CCDC157-
depleted cells, Golgi membranes exhibited a characteristic
ring-shaped organization as observed for both GM130 and
TGN46 staining (Fig. 4, A, B, and E). Electronmicroscopy studies
confirmed that Golgi stacks had altered ultrastructure in TTC17-
depleted cells, characterized by enlarged and swollen Golgi cis-
ternae, and in CCDC157-depleted cells, most likely caused by
accumulated and coalesced transport carriers in close proximity
of Golgi membranes (Fig. 4 F). Along with the perturbed Golgi
complex architecture, the distributions of ER exit sites were also
altered upon candidate gene knockdown (Fig. S2 A), with no
obvious changes in the distribution and morphology of the ER
(Fig. S2 B).
How could the selected factors play a role in protein transport
and secretion, and secretory pathway organization? To address
this question, we looked for interacting partners using the Bio-
Plex network, which encompasses results aiming at identifying
binding partners of proteins encoded by the human genome
(Huttlin et al., 2015, 2017). Interrogation of this resource iden-
tified TTC17-interacting proteins, including exclusively ER- and
Golgi-resident proteins and cargo proteins transported along the
secretory pathway (Fig. 5 A). Interacting partners of CCDC151
include the SNARE-associated protein SNAPIN, GTPase Rab-Like
protein 5, and Golgin A5 (Fig. 5 B). Interacting partners of
C10orf88 include Rab protein GDI2, clathrin heavy chain,
clathrin adaptors accessory protein CCDC91, and plasma mem-
brane proteins NCKAP1 and LILRB4 (Fig. 5 C). The BioPlex re-
source does not contain a network for CCDC157. Taken together,
these data supported a direct role of the selected factors on the
secretory pathway function, prompting us to probe their site of
action.
A Pfam domain analysis (Finn et al., 2016) or TMHMM
software (Krogh et al., 2001) did not predict TMD for the se-
lected factors, whereas the HMMTOP algorithm (Tusna´dy and
Simon, 2001) yielded one TMD for TTC17 (TMHMM and
HMMTOP are two transmembrane protein topology prediction
methods, based on a hidden Markov model). To assess the
subcellular localization of the selected factors, we performed
immunofluorescence microscopy on HeLa cells using specific
antibodies directed against the endogenous proteins, after per-
meabilization with digitonin and extensive washing. This pro-
cedure allows the removal of soluble cytoplasmic pool of
proteins, highlighting their potential association with intracel-
lular compartments. This approach revealed a close proximity
between CCDC151 and the centrosomal marker centrin-3 (Fig. 5,
D and E). This location is consistent with the interacting part-
ners of CCDC151 revealed by BioPlex and the Golgi membrane
phenotype observed in CCDC151-depleted cells (Fig. 4, A and B).
Indeed, interacting partners of CCDC151 included CEP170 (Fig. 5 B),
a key component of the centrosome that functions as a
microtubule-organizing center, essential for the perinuclear
localization of Golgi membranes (Rios and Bornens, 2003).
Hence, we hypothesize that CCDC151 is a bridging factor be-
tween the centrosome and Golgi membranes via interactions
with Golgin A5 and CEP170, thereby contributing to the
maintenance of Golgi architecture. Disruption of this functional
link after depletion of CCDC151 may result in Golgi membrane
dispersion throughout the cytoplasm. Of interest, our results
also revealed the presence of TTC17 and CCDC157 on Golgi
Bassaganyas et al. Journal of Cell Biology 5
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Figure 3. Identification of new factors for protein transport and secretion. (A) 62 genes with unknown or poorly characterized function that were
identified as candidate genes either in the lower (39 genes) or upper quartiles (23 genes) were selected for a secondary screen using a secretion assay based on
the detection of ss-HRP. HeLa–ss-HRP cells were plated in a 96-well plate prearrayed with specific smart pool siRNAs. After 3 d, cells were washed and
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membranes (Fig. 5, F, G, and I). A residual signal of C10orf88
was mainly diffuse in the cytoplasm (Fig. 5, H and I). The
subcellular location of TTC17 and CCDC157, and the conse-
quence of their knockdown on Golgi membranes, prompted us
to further characterize these two factors.
CCDC157 is required for fusion events with Golgi membranes
A permanent flux of membrane traffics to and from the Golgi
complex. BFA has been regularly used to study Golgi membrane
dynamics, inducing a complete fusion of Golgi membranes with
the ER and endosomes via tubule formation (Lippincott-
Schwartz et al., 1989) and the relocation of peripheral matrix
Golgi proteins such as GM130 and GRASP65 to the ER exit site
(Mardones et al., 2006). First, we tested whether Golgi mem-
brane reorganization was altered upon BFA treatment in TTC17-
and CCDC157-depleted cells. HeLa cells were transfected with
specific individual siRNAs and, after 3 d, treated with BFA.
Immunofluorescence microscopy revealed that GM130 com-
pletely dispersed upon 30 min of BFA treatment in control cells
and in most of the CCDC157- and TTC17-depleted cells (Fig. 6, A
and B). Next, we tested the effects of CCDC157 and TTC17
knockdown on Golgi membrane reassembly after BFA washout,
which is mediated by fusion events. In control and TTC17-
depleted cells, Golgi membrane reassembly occurred in most
cells after 60 min, while in CCDC157-depleted cells, GM130 re-
mained completely dispersed (Fig. 6, A and B). Given these re-
sults demonstrating that Golgi membrane reassembly after BFA
washout was strongly altered upon CCDC157 knockdown, we
assessed the distribution of the ER-Golgi intermediate com-
partment (ERGIC) by immunofluorescence microscopy using an
anti-ERGIC53 antibody. ERGIC is a collection of tubulovesicular
membrane clusters that allow delivery of secretory cargo from
ER exit sites to the Golgi complex in a COPII vesicle-dependent
manner via homotypic and heterotypic fusion events (Lorente-
Rodr´ıguez and Barlowe, 2011). In control and TTC17-depleted
cells, ERGIC53 staining mainly localized in the proximity of
Golgi membranes, whereas in CCDC157-depleted cells, ERGIC53
staining was more dispersed throughout the cytoplasm (Fig. 6, C
and D). These results suggested that CCDC157 could act as an
important factor for the fusion of transport carriers with the
Golgi complex.
To further test a role in membrane fusion, we assessed the
impact of CCDC157 knockdown on the distribution of transport
carriers derived from the endocytic pathway that fuse with Golgi
membranes (Johannes and Popoff, 2008). We performed im-
munofluorescence microscopy experiments using an antibody
targeting the transferrin (Tf) receptor (TfR), which, although it
is mainly recycled to the plasma membrane after endocytosis
(Huebers and Finch, 1987), is also retrieved to Golgi membranes
(Snider and Rogers, 1985; Woods et al., 1986; Jin and Snider,
1993), and an antibody targeting EEA1, a marker of early endo-
somes, critical for endosomal trafficking (Barysch et al., 2009).
We hypothesized that while TfR-containing transport carriers
do not mainly fuse with Golgi membranes (Snider and Rogers,
1985; Woods et al., 1986), alteration of these fusion events could
lead over time to the accumulation of transport carriers in the
vicinity of the Golgi apparatus. In TTC17-depleted cells, the
distribution of TfR and EEA1 was not markedly affected com-
pared with control cells (Fig. 6, E and F; and Fig. S3). However, in
CCDC157-depleted cells, the distribution of both TfR and EEA1
was strongly altered, most of the signal being coalesced to the
perinuclear area in the form of enlarged TfR- and EEA1-positive
vesicles, surrounded by Golgi membranes (Fig. 6, E–H; and Fig.
S3). In line with these observations, the uptake as well as the
recycling of Tf were reduced upon CCDC157 knockdown (Fig.
S4). Altogether, these results suggested that in the absence of
CCDC157, incoming carriers deriving from the endocytic path-
way accumulated and coalesced in close proximity to Golgi
membranes, strengthening CCDC157 as being an important
factor for the fusion of transport carriers with the Golgi
complex.
TTC17 is required for the polarized arrangement of Golgi
cisternae and posttranslational modifications
In addition to being a gate entrance and a major sorting station,
the Golgi apparatus allows posttranslational modifications such
as glycosylation. This process is spatially regulated, being de-
pendent on accurate localization of specific enzymes acting se-
quentially from the cis- to trans-Golgi cisternae. Does altered
Golgi membrane organization in CCDC157- and TTC17-depleted
cells impact Golgi polarization and create glycosylation defects?
To address these questions, we first assessed the localization of
GM130 and TGN46, cis- and trans-Golgi markers, respectively,
in cells incubated in the presence or absence of nocodazole.
Nocodazole is a microtubule-depolymerizing agent that causes
Golgi ribbon dissociation and hence Golgi stack dispersion (Cole
et al., 1996), facilitating the visualization of Golgi-resident pro-
tein segregation in individual Golgi stacks (Fig. 7, A and D). In
incubated for 8 h with complete medium. HRP secretion was monitored from the supernatant by chemiluminescence and normalized to internal HRP activity
(n = 2). HRP quantification from cells transfected with control siRNA (in yellow) and siRNA targeting SCFD1 (in red) was used as negative and positive controls,
respectively. Genes selected for further analysis are highlighted in green. Entire data are reported in Table S2. (B) HeLa TAC-GFP cells were transfected with
the indicated specific individual siRNA and, after 3 d, knockdown efficiency of targeted genes was monitored by RT-PCR. (C) HeLa TAC-GFP cells were
transfected with the indicated specific individual siRNA and after 3 d, surface and total TAC expressions (top panels) and surface/total TAC expression ratio
(bottom panels) were analyzed by flow cytometry in living cells. In the bottom panels, lower and upper quartiles are set on control cells and applied to the other
experimental conditions. (D) Quantification of the enrichment of cells in the lower quartile compared with the upper quartile as presented in C, bottom panels
(mean of n = 4 ± SEM; two-tailed Student’s t test for comparison to control condition siCtr; *, P < 0.05; **, P < 0.01). (E and G)HeLa cells were transfected with
the indicated specific individual siRNA and after 3 d, surface MHC-I expression was analyzed on cells fixed with PFA without cell permeabilization by flow
cytometry (E) and immunofluorescence microscopy (G; nuclei were stained with DAPI). Scale bars, 20 µm. (F) Quantification of the mean of fluorescence of
MHC-I surface expression presented in E. Values were normalized to control sample (mean of n = 4 ± SEM; two-tailed Student’s t test for comparison to control
condition siCtr; *, P, < 0.05; **, P < 0.01; ***, P < 0.001).
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Figure 4. Newly identified factors are essential for secretory pathway organization. (A and B) HeLa cells were transfected with indicated specific
individual siRNAs and after 3 d, analyzed by immunofluorescence microscopy using antibodies against GM130 (A) and TGN46 (B), respectively. Nuclei were
stained with DAPI. Scale bars, 20 µm. (C) Quantification of the percentage of cells with fragmented Golgi complex after transfection with the indicated specific
individual siRNAs. For unbiased analysis of Golgi membranemorphology, the classifier of the CellProfiler Analyst was used (seeMaterials andmethods). At least
200 cells were analyzed for each independent experiment (mean of n = 3 ± SEM; two-tailed Student’s t test for comparison to control condition siCtr; *, P <
0.05). (D and E) Left: HeLa cells were transfected with indicated specific individual siRNAs and after 3 d, analyzed by immunofluorescence microscopy using an
anti-GM130 antibody. Nuclei were stained with DAPI. Scale bars, 50 µm. Right panel in D shows the quantification of Golgi surface area. For unbiased analysis
Bassaganyas et al. Journal of Cell Biology 8
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control cells, GM130 and TGN46 staining only partially colo-
calized (Pearson’s correlation coefficient r = 0.507). Similar re-
sults were obtained in CCDC157-depleted cells (r = 0.495).
Conversely, in TTC17-depleted cells, GM130 and TGN46 staining
showed a high degree of colocalization (r = 0.805; Fig. 7, A–D),
suggesting that protein localization in their respective cisternae
was perturbed with no further segregation of cis- and trans-
Golgi markers. In addition, we observed that upon TTC17
knockdown, nocodazole failed to induce complete Golgi mem-
brane fragmentation, although the microtubule cytoskeleton
was entirely depolymerized (Fig. 7 C). We hypothesized that the
dramatic alteration of Golgi membrane architecture upon TTC17
depletion prevents efficient Golgi stack dissociation.
We next tested whether the loss of Golgi polarization in
TTC17-depleted cells impairs cargo protein glycosylation. The
lysosomal protein LAMP2 is highly glycosylated during its
transport across the secretory pathway, increasing its molec-
ular weight (Stewart et al., 2017). In control and CCDC157-
depleted cells, immunoblotting analysis revealed LAMP2
mainly as a fully processed 100-kD band. However, in TTC17-
depleted cells, a smaller form of ∼80 kD became apparent, in-
dicating incomplete LAMP2 processing, likely related to a
glycosylation defect (Fig. 7 E). These results established TTC17
as an important factor for Golgi membrane structure and po-
larized arrangement of Golgi cisternae, enabling cargo protein
processing and transport.
Discussion
Although a large number of gene products involved in protein
transport was identified in recent decades (Novick et al., 1980;
Braell et al., 1984; Bard et al., 2006; Wendler et al., 2010), the list
is far from complete, and several crucial issues are emerging.
Indeed, in eukaryotic cells, evolution has given rise to an in-
credible diversity and complexity of cargo molecules, whose
efficient and accurate transport along the secretory pathway is
of paramount importance for organismal development, cell and
tissue homeostasis, immunity, metabolic regulation, nerve
transmission, and healthy aging (Rothman and Orci, 1992;
So¨llner and Rothman, 1994; Lee et al., 2004; Zanetti et al., 2012;
Guo et al., 2014; Malhotra and Erlmann, 2015). An increasing
number of studies has demonstrated that cells are endowed with
specific structural and functional machinery that can be tightly
regulated to cope with the whole spectrum of cargo proteins
(Cancino et al., 2014; Ma et al., 2018; Raote et al., 2018; Lopes-da-
Silva et al., 2019). In this context, it is essential to develop ver-
satile and high-throughput screening strategies to uncover how
secretory pathways are adapted to and are regulated in response
to intrinsic demands and environmental cues, and altered in
diseases.
In this study, we implemented an unbiased pooled genome-
wide CRISPRi screen allowing us to efficiently identify new
components of the secretory pathway. Major benefits have al-
ready been associated with pooled CRISPR screens, establishing
such approaches as powerful tools for systematically defining
gene function in mammalian cells (Gilbert et al., 2014; Shalem
et al., 2015; Canver et al., 2018). The efficiency of our strategy
relies on the combination of key parameters. First, we used a
complementary reporter system associated with cell selection
based on the ratio of two fluorescent signals. This reporter
system allowed monitoring surface/total TAC expression ratio
variations and therefore differential FACS-based cell sorting,
directly relative to the transport of TAC protein to the cell sur-
face. The strengths of this strategy were exemplified with
Sec61A knockdown, where we could avoid following up unde-
sirable phenotypes such as defective TAC protein synthesis.
Second, as the secretory pathway is of critical importance for
cell homeostasis and viability, gene expression was systemati-
cally down-regulated using the dCas9 fused to a KRAB effector
domain for CRISPRi, instead of the active Cas9 for CRISPR
knockout (Shalem et al., 2015; Kampmann, 2018). The resulting
transcriptional repression of target genes preserved minimal
gene expression, preventing massive cell death after down-
regulation of key factors for protein and membrane traffick-
ing. Third, the combination of the dual fluorescent reporter with
the CRISPRi system allowed us to monitor TAC transport and
perform FACS-based cell sorting at a relatively early time point
(7 d after lentivirus transduction), which also would reduce ex-
cessive cell death after gene knockdown. Altogether, combining
these technical parameters makes our approach a noteworthy
advance compared with previous RNA interference–based
genome-wide screens and resulted in a powerful platform al-
lowing us to focus on the identification of genes involved in
secretory pathway function and organization.
Our work highlighted several factors whose knockdown in-
hibited or promoted the trafficking of both exogenous and en-
dogenous cargo proteins. Various genes encoding proteins
known to be involved in calcium homeostasis, signaling path-
ways, or lysosomal activity, among others (Table S2), strengthen
the idea that there are functional links between these cellular
processes and the secretory pathway. In addition, several pro-
teins with unknown or poorly characterized function were
identified. In particular, TMEM167A, FAM46A, and USP32,
which promote secretion upon knockdown, as well as C10orf88,
WDR7, YPEL5, TMEM161, FAM162B, and GPR162, which inhibit
secretion upon knockdown, deserve greater attention. For
of Golgi membrane surface area, cells (465 control cells and 388 TTC17-depleted cells) were analyzed with the CellProfiler Analyst (See Materials and
methods). Mann–Whitney U test for comparison to control condition siCtr; ***, P < 0.001. Right panel in E shows the quantification of the percentage of cells
with Golgi membranes with a ring-shape structure using the classifier of the CellProfiler Analyst (See Materials and methods). At least 200 cells were analyzed
for each independent experiment (mean of n = 3 ± SEM; two-tailed Student’s t test for comparison to control condition siCtr; *, P < 0.05). (F) Transmission
electron microscopy of Golgi membranes in control cells and TTC17- and CCDC157-depleted cells. Scale bars, 500 nm. In a given cell with altered Golgi
membranes, all individual Golgi stacks had altered ultrastructure characterized by enlarged and swollen Golgi cisternae (blue arrowheads) in TTC17-depleted
cells, and most likely accumulated and coalesced transport carriers in close proximity to Golgi membranes (red arrowheads) in CCDC157-depleted cells,
respectively.
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Figure 5. Newly identified factors localize along the secretory pathway. (A–C) BioPlex 2.0 analysis displaying interacting partners of TTC17 (A), CCDC151
(B), and C10orf88 (C). Functional proteins acting along the secretory pathway or cargo proteins transported along the ER-Golgi apparatus are highlighted in red.
(D–H) HeLa cells were processed for cytosolic washout. Then, the colocalization of CCDC151 (D and E), TTC17 (F), CCDC157 (G), and C10orf88 (H; green) with
TGN46 or centrin 3 (red) was assessed by immunofluorescence microscopy. Nuclei were stained with DAPI. Scale bars, 20 µm in D and F–H. Scale bars, 8 µm in
E. Intensity profile graphs showing the relative localization of the indicated proteins were obtained along the lines shown in the confocal micrograph inserts.
(I) Pearson’s correlation coefficient of colocalization for the indicated proteins (r) derived from confocal micrographs (n = 30).
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Figure 6. CCDC157 is required for fusion events with Golgi membranes. (A) Control HeLa cells and cells depleted of TTC17 or CCDC157 were incubated
with 5 µg/ml BFA for the indicated times, after which cells were analyzed by immunofluorescence microscopy using an anti-GM130 antibody. For BFA washout,
cells were incubated with BFA for 30 min, washed extensively, and incubated in BFA-free medium before immunofluorescence microscopy analysis. Nuclei
were stained with DAPI. Scale bars, 20 µm. (B) Quantification of cells with dispersed Golgi membranes using an anti-GM130 antibody as described in A. 200
cells were counted per condition for each individual experiment (mean of n = 3 ± SEM). (C) Control HeLa cells and cells depleted of CCDC157 or TTC17 were
analyzed by immunofluorescence microscopy using anti-ERGIC and anti-GM130 antibodies. Nuclei were stained with DAPI. Scale bars, 10 µm. (D) Pearson’s
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example, USP32 is a membrane-bound ubiquitin protease lo-
calized in the Golgi apparatus and overexpressed in breast
cancer (Akhavantabasi et al., 2010); and GPR162 is an orphan
GPCR. Compelling evidence suggests that the activation of
GPCRs on Golgi membranes is critical for protein and membrane
trafficking, but their identities remain elusive (Dı´az Añel and
Malhotra, 2005; Cancino et al., 2014; Eichel and von Zastrow,
2018). Altogether, our results provide a valuable resource to gain
future important insights into fundamental mechanisms gov-
erning protein and membrane transport.
Our study further characterized two of the newly identified
factors, TTC17 and CCDC157, as new actors of critical importance
for the structure and function of Golgi membranes. Although
additional studies will be required to fully decipher their roles,
our results suggest that like other coiled-coil proteins (Wong and
Munro, 2014; Cheung and Pfeffer, 2016) CCDC157 could be part
of a tethering complex required for fusion events at the Golgi
membranes. Furthermore, phenotypes observed in TTC17-
depleted cells associated with TTC17 interacting partners in-
volved in sphingomyelin metabolism (ENPP7 and NAAA; Fig. 5
A; Duan et al., 2003; Tsuboi et al., 2007) suggest that TTC17 could
play a role in lipid production and distribution, critical param-
eters for Golgi membrane organization (van Galen et al., 2014;
Campelo et al., 2017). Deciphering how CCDC157 and TTC17 are
recruited to membranes and how their functions are coordi-
nated with other structural factors and components of the
tethering and fusion machinery will be of major interest.
In conclusion, while initial screens performed in yeast re-
vealed the basic principles conserved across species (Novick
et al., 1980), and, more recently, arrayed RNA interference
screens revealed key players that function in metazoans (Bard
et al., 2006; Saito et al., 2009; von Blume et al., 2009), our pooled
CRISPRi screen unveiled new components that further refine
the steps along the secretory pathway. In addition, we anticipate
that the adaptation of our screening platform to specific cargo
proteins, professional secretory cell types, and intrinsic or en-
vironmental challenges will open new and stimulating per-
spectives for a better understanding of the secretory pathway
architecture in health and disease, for both conventional and
unconventional secretion (Zhang and Schekman, 2013; Cruz-
Garcia et al., 2018; Villeneuve et al., 2018; Chiritoiu et al., 2019).
Materials and methods
Antibodies, reagents, and plasmids
Antibodies used in this study included mouse monoclonal anti-
bodies anti-TAC conjugated to PE (BioLegend; 356103), anti-
GM130 (BD Biosciences; 610822), anti-Sec31A (BD Biosciences;
612351), anti–MHC-I (Thermo Fisher Scientific; MA1-70111),
anti-EEA1 (BD Biosciences; 610457), anti–α-tubulin (Thermo
Fisher Scientific; 62204), anti-LAMP2 (BioLegend; 354302) and
anti-centrin3 (Novus Biologicals; H00001070-M01), a mouse
polyclonal antibody anti-C10orf88 (Abcam; ab169106), a sheep
polyclonal antibody anti-TGN46 (BioRad; AHP500), a rabbit
monoclonal antibody anti-ERGIC53 (Abcam; ab125006), rabbit
polyclonal antibodies anti-CNX (Abcam; ab22595), anti-CCDC151
(Abcam; ab151469), anti-TTC17 (Atlas Antibodies; HPA038508),
anti-CCDC157 (GeneTex; GTX45090), anti-TfR (Abcam; ab84036);
secondary antibodies donkey anti-sheep IgG–Alexa Fluor 568
(A21099), goat anti-mouse IgG–Alexa Fluor 488 (A11001), goat
anti-mouse IgG–Alexa Fluor 568 (A11004), goat anti-rabbit IgG–
Alexa Fluor 568 (A11011), and goat anti-rabbit IgG–Alexa Fluor
488 (A11034; Thermo Fisher Scientific); and a secondary antibody
mouse IgGκ conjugated to HRP (Santa Cruz Biotechnology; sc-
516102).
Reagents used in this study were obtained from the following
sources: Dulbecco’s PBS (D8662), BFA (B6542), nocodazole
(M1404), puromycin (P9620), G-418 (4727878001), protease in-
hibitor cocktail (05892953001), trypsin (T3924), penicillin/
streptomycin (P0781), and L-glutamine (G7513) were from
Sigma-Aldrich. Q5 HF DNA polymerase (M0491L), Phusion HF
DNA polymerase (M0530L), Phusion HF reaction Buffer
(B0518S), and dNTPs (N0447S) were from New England Biolabs.
T4 DNA ligase (EL0011), FBS (10270-106), Lipofectamine 2000
transfection reagent (12566014), DH5α bacteria (18258012), Re-
store Plus reagent (46430), ProLong Gold antifade reagent with
DAPI (P36935), OptiMEM (319885062), and Tf conjugated with
Alexa Fluor 647 (T23366) were from Thermo Fisher Scientific.
TransIT-2020 transfection reagent (5405) and TransIT-293
transfection reagent (MIR2700) were from Mirus. Polybrene
(TR-1003-G) and digitonin (11024-24-1) were from Merck.
0.45 µm low protein binding membrane (28145-479) was from
VWR International. NucleoSpin Blood L kit (740569.10) was
from Macherey-Nagel. ECL Western Blotting Detection Reagent
(RPN2106) was from GE Healthcare. DMEM (D6546) was from
Molecular Probes. SPRI AMPure XL beads were from Beckman
Coulter. White CulturPlate 96-well plates (6005680) were from
PerkinElmer. RNAeasy Plus Mini kit (74134) was from QIAGEN.
Cloned AMV First-Strand cDNA Synthesis kit (12328032) was
from Invitrogen. Mouse IgGκ Isotype (400111) was from Bio-
Legend. Universal mycoplasma detection kit (30-1012K) was
from American Type Culture Collection (ATCC).
Plasmids included pCMV6-AC-IL2R-GFP (Origene plasmid
RG215768). pHR-SFFV-dCas9-BFP-KRAB was a gift from S. Qi
(Stanford University, Stanford, CA) and J. Weissman (University
of California, San Francisco, San Francisco, CA; Addgene plasmid
46911; Gilbert et al., 2013). pU6-sgRNA EF1Alpha-puro-T2A-BFP
was a gift from J. Weissman (Addgene plasmid 60955; Gilbert
correlation coefficient of colocalization between ERGIC53 and GM130 (n = 24; Two-tailed Student’s t test for comparison to control condition siCtr; ***, P <
0.001). (E) Control HeLa cells and cells depleted of CCDC157 or TTC17 were analyzed by immunofluorescence microscopy using anti-TfR and anti-TGN46
antibodies. Nuclei were stained with DAPI. Scale bars, 10 µm. Arrowheads point at enlarged and coalesced TfR-positive vesicles, surrounded by Golgi
membranes. (F) Pearson’s correlation coefficient of colocalization between TfR and TGN46 (n = 27; two-tailed Student’s t test for comparison to control
condition siCtr; **, P < 0.01; ***, P < 0.001). (G) Control HeLa cells and cells depleted of CCDC157 were analyzed by immunofluorescence microscopy using
anti-EEA1 and anti-TfR antibodies. Nuclei were stained with DAPI. Scale bars, 10 µm. (H) Pearson’s correlation coefficient of colocalization between EEA1 and
TfR (n = 27; two-tailed Student’s t test for comparison to control condition siCtr; ***, P < 0.001).
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Figure 7. TTC17 is required for the polarized arrangement of Golgi cisternae and posttranslational modifications. (A–C) Control HeLa cells (A) and cells
depleted of CCDC157 (B) or TTC17 (C) were incubated in the presence or absence (DMSO) of 500 ng/ml nocodazole for 2 h, and analyzed by immunofluo-
rescence microscopy with anti-TGN46 and anti-GM130 antibodies. Depolymerization of the microtubule cytoskeleton was monitored with an anti–α-tubulin
antibody. Nuclei were stained with DAPI. Scale bars, 10 µm. Insets from A, B, and C, show Golgi stack dispersion after nocodazole treatment. Intensity profile
graphs of TGN46 and GM130 colocalization derived along the lines indicated in the confocal micrograph inserts. (D) Pearson’s correlation coefficient of
colocalization between TGN46 and GM130 from confocal micrographs acquired for control cells, and cells depleted of CCDC157 or TTC17 after nocodazole
treatment (n = 24; two-tailed Student’s t test for comparison to control condition siCtr; ***, P < 0.001; ns, statistically nonsignificant). (E) Total cell lysates of
control HeLa cells and cells depleted of TTC17 or CCDC157 were analyzed by immunoblotting with anti-LAMP2 and anti–α-tubulin antibodies. Results are
representative of three independent experiments.
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et al., 2014). pCMV-VSV-G was a gift from B. Weinberg
(Whitehead Institute for Biomedical Research, Cambridge, MA;
Addgene plasmid 8454; Stewart et al., 2003). psPAX2 was a gift
from D. Trono (E´cole polytechnique fe´de´rale de Lausanne,
Lausanne, Switzerland; Addgene plasmid 12260). hCRISPRi-v2
genome-wide library was a gift from J. Weissman (Addgene
pooled library 83969; Horlbeck et al., 2016a).
Cell culture
All cell lines, HeLa cells (ATCC), HeLa–ss-HPR cells (a gift from
V. Malhotra, Centre for Genomic Regulation, Barcelona, Spain),
HeLa TAC-GFP cells (this paper), HeLa TAC-GFP dCas9-KRAB
cells (this paper), and HEK293T cells (ATCC) were grown in
complete medium consisting of DMEM (Molecular Probes;
D6546) containing 10% FBS (Thermo Fisher Scientific; 10270-
106), 100 U/ml penicillin, 100 µg/ml streptomycin (Sigma-
Aldrich; P0781), and 2 mM L-glutamine (Sigma-Aldrich; G7513)
at 37°C with 5% CO2. All cell lines were tested every month using
ATCC universal mycoplasma detection kit (ATCC; 30-1012K) to
confirm they were clear of contamination by mycoplasma.
To generate a HeLa cell line stably expressing GFP-tagged
TAC protein, we transfected HeLa cells with pCMV6-AC-IL2R-
GFP (Origene; plasmid RG215768) using TransIT-2020 trans-
fection reagent (Mirus; 5405), following the manufacturer’s
recommendations, and after 2 d, transfected cells were selected
with 600 µg/ml G-418 (Sigma-Aldrich; 4727878001) during
1 wk. Then, GFP-positive cells were isolated by FACS, and
single cells were collected in 96-well plates. After expansion
into the 6-well format, TAC-GFP expression was assessed from
clonal lines by flow cytometry and immunofluorescence mi-
croscopy analysis. The GFP signal allows monitoring the total
TAC expression, whereas the pool expressed at the cell surface
can be assessed using a PE-conjugated antibody, which recog-
nizes the extracellular domain of the TAC protein. To generate
HeLa TAC-GFP dCas9-KRAB cells, we transduced HeLa TAC-
GFP cells with lentivirus to express dCas9-KRAB-BFP fusion
protein (see section Lentivirus production and transduction).
After 2 d, transduced cells were sorted for GFP- and BFP-
positive cells.
siRNA-mediated knockdown
Specific individual siRNA and smart pools siRNA were trans-
fected in HeLa cells, HeLa–ss-HPR cells, and HeLa TAC-GFP cells
using Lipofectamine 2000 transfection reagent (Thermo Fisher
Scientific; 12566014) following the manufacturer’s recom-
mendations. Individual siRNA and smart pools siRNA were
purchased from Dharmacon. The siRNA sequences used were






A-39, CCDC151 59-GCUCAAGGCCUAUCUAAUG-39, 59-GAAGGCUGC
CCGAAUACAA-39, 59-CGGGAACGCUACAUAAGUG-39, 59-GCACAU
UACCAGCGUGUAC-39, and C10orf88 59-GCACAUUGAUGAUAAGAU
U-39, 59-GAAAUAAGACCGAGUGUCA-39, 59-GCUCAGCAGUUGAUG
GAUA-39, 59-GGGAUACCUCUAAGACAUU-39. After incubation for 72
h, total RNA was extracted and knockdown efficiency was assessed
by RT-PCR.
CRISPRi-mediated knockdown
Gene-specific CRISPRi sgRNA oligonucleotide sequences used
were the following: Gal4 59-GAACGACTAGTTAGGCGTGTA-39,
Sec61A 59-GGCTAGCACTGACGTGTCTCT-39, SCFD1 59-GAGCAG
CCAGTATTCGGGAA-39, and Sec24A 59-GACATGATGACTGGG
TTGGA-39. Forward sgRNA oligonucleotides were designed with
59-TTG and 39-GTTTAAGAGC overhangs, and reverse sgRNA
oligonucleotides were designed with 59-TTAGCTCTTAAAC and
39-CAACAAG overhangs. Oligonucleotides were diluted to
100 µM in water, and 1 µl of forward and reverse oligo was
combined in a 50-µl reaction containing 200 mM potassium
acetate, 60 mM Hepes, pH 7.4, and 4 mM magnesium acetate.
Oligonucleotides were incubated for 5 min at 95°C and slow-
cooled (0.1°/s) for annealing. Annealed oligos were diluted
1/40, and 1 µl of insert was ligated into 10 ng of digested vector
(pU6-sgRNA EF1Alpha-puro-T2A-BFP; Addgene; plasmid 60955
digested with BstXI and Blpl) using T4 DNA ligase (Thermo
Fisher Scientific; EL0011) in a final volume of 10 µl. Ligation was
allowed to proceed for 1 h. Ligated products were transformed
into DH5α bacteria (Thermo Fisher Scientific; 18258012). After
lentivirus production (see section Lentivirus production and
transduction), TAC-GFP-dCas9-KRAB HeLa cells were infected,
and knockdown efficiency was monitored 7 d after transduction
by RT-PCR. TAC-GFP expression was assessed by flow cytometry
analysis.
Lentivirus production and transduction
Lentivirus was generated in HEK293T cells using TransIT-293
transfection reagent (Mirus; MIR2700) following the manu-
facturer’s recommendations. At 50% confluence, HEK293T cells
incubated in complete medium lacking penicillin/streptomycin
were transiently transfected with a lentiviral vector, either pHR-
SFFV-dCas9-BFP-KRAB (Addgene plasmid 46911) for dCas9-KRAB
fusion protein expression, pU6-sgRNA EF1Alpha-puro-T2A-
BFP (Addgene plasmid #0955) containing gene-specific CRISPRi
sgRNA oligonucleotides, or hCRISPRi-v2 library (Addgene
pooled library 83969) for a pooled genome-wide CRISPRi
screen, together with packaging plasmids pCMV-VSV-G
(Addgene plasmid 8454) and psPAX2 (Addgene plasmid 12260)
at a 4:1:3 ratio. Transfection was performed using one 10-cm
dish for dCas9-KRAB fusion protein expression and for each
specific sgRNA, and using two 15-cm dishes for hCRISPRi-v2
library. After transfection (24 h), the medium was refreshed,
and after an additional 24 h, virus was collected and filtered
through a 0.45-µm low protein binding membrane (VWR In-
ternational; 28145-479). For dCas9-KRAB fusion protein ex-
pression and CRISPRi-mediated knockdown, 1 ml of medium
was used immediately for infection of ∼500,000 target cells
plated in 6-well plate in a final volume of 2 ml. For a pooled
genome-wide CRISPRi screen, ∼200 million TAC-GFP-dCas9-
KRAB HeLa cells plated in thirty 15-cm dishes were infected at
an MOI of 0.3. Medium was supplemented with 8 µg/ml pol-
ybrene (Merck; TR-1003-G) lacking penicillin/streptomycin.
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After 24 h, medium was replaced with fresh medium, and after
an additional 24 h, high BFP-positive cells expressing dCas9-
KRAB fusion protein were sorted by FACS. For CRISPRi-
mediated knockdown and a pooled genome-wide CRISPRi
screen, 48 h after infection, 2 µg/ml puromycin (Sigma-
Aldrich; P9620) was added to select transduced cells.
Pooled genome-wide CRISPRi screen and Illumina library
construction and sequencing
Approximately 200 million HeLa cells stably expressing TAC-
GFP and dCas9-KRAB fusion protein were transduced with the
hCRISPRi-v2 library (Addgene; 83969) at an MOI of 0.3 to en-
sure no more than one viral integration event per cell. The
CRISPi-v2 library comprised 104,535 sgRNAs targeting 18,905
human genes. Each sgRNA of the library targeted the TSS of the
respective genes in regions of low nucleosome occupancy
avoiding genomic DNA compaction to impact Cas9 binding
(Horlbeck et al., 2016a,b). 2 d after infection, an aliquot of cells
was analyzed by FACS to confirm transduction efficiency, and
then cells were cultured with 2 µg/ml puromycin (Sigma-
Aldrich) to remove uninfected cells. After five additional days,
cells were trypsinized, washed extensively, and plated with
fresh medium for 18 h, allowing recovery of transmembrane
protein expression at the cell surface. Cells were then detached
using 0.5 mM EDTA, resuspended in blocking buffer (OptiMEM
containing 5% FBS), and stained for TAC surface expression
using a PE-conjugated anti-TAC antibody during 1 h at 4°C. Fi-
nally, live cells were sorted by FACS following the PE/GFP flu-
orescence ratio, selecting the upper and lower quartile,
respectively. 10 million cells were sorted for each fraction
(Parnas et al., 2015; Park et al., 2017; Menzies et al., 2018). Cell
sorting was performed using a FACSAria sorter. Two indepen-
dent screens were performed. After FACS sorting, cells were
centrifuged, and pellets were frozen until processing.
Genomic DNA was extracted from four distinct cell pop-
ulations, corresponding to the upper and lower quartile of the
PE/GFP fluorescence ratio, from two independent screens, using
the NucleoSpin Blood L kit (Macherey-Nagel; 740569.10) ac-
cording to the manufacturer’s instructions. Then, for each
sample, all genomic DNA was amplified by PCR to enrich sgRNA
sequences. Each 100 µl PCR reaction contained 1× Phusion HF
reaction Buffer (NEB; B0518S), 3% vol/vol DMSO, 0.4 µM of each
forward and reverse primermix (Integrated DNATechnologies),
0.2 mM dNTPs (NEB; N0447S), 40 U/ml Phusion HF DNA pol-
ymerase (NEB; M0530L), and 2 µg genomic DNA. PCR primer
sequences for the forward primers with specific barcode for de-









AAAAGGAAACTCACCCT-39, The PCR primer sequence for the
common reverse primer was 59-CAAGCAGAAGACGGCATACGA
GATCGACTCGGTGCCACTTTTTC-39. PCR cycling conditions
used included 1× 98°C for 30 s, 23× 98°C for 30 s, 56°C for 15 s,
72°C for 15 s, and 1× 72°C for 10 min. For each sample, PCR
products were pooled, size-selected using SPRI AMPure XL
beads (Beckman Coulter) following the manufacturer’s recom-
mendations, and quantified on a Qubit and run on a Bioanalyzer
(Agilent). The four libraries were pooled to a total concentration
of 10 nM and subjected to DNA sequencing on a HiSeq2500
(Illumina) sequencer. Samples were sequenced with the rapid
run mode of the single-ended 50 bp, following the manu-
facturer’s recommendations, using a custom sequencing primer:
59-GTGTGTTTTGAGACTATAAGTATCCCTTGGAGAACCACC
TTGTTG-39.
For data analysis, raw sequencing reads were aligned to the
v2CRISPRi library sequences using Bowtie 2, and data were
analyzed using theMAGeCK algorithm (Li et al., 2014). For genes
with multiple independent TSS targeted by the sgRNA library,
we calculated phenotype and P values independently for
each TSS.
Secondary screen using an HRP secretion assay
Aswe intended to validate hit genes found in our primary screen
with a secondary screen, hit genes were selected as interesting
candidates among those with a P value <0.01 and a log2 fold
change (lfc) less than −0.5 for genes enriched in the lower
quartile and a lfc >0.3 for genes enriched in the upper quartile
(see Tables S1 and S2). The difference of lfc cutoff applied for the
selection of candidate genes relied on the weaker phenotypes
observed on TAC transport for genes enriched in the upper
quartile compared with those enriched in the lower quartile.
Thus, 62 genes identified either in the lower (39 genes) or upper
quartiles (23 genes) as candidate genes with an unknown or
poorly characterized function were selected for a secondary
screen using a secretion assay based on the detection of ss-HRP.
HeLa cells stably expressing ss-HRP were transfected in a 96-
well plate prearrayed with specific smart pools siRNA (Dhar-
macon) targeting selected genes, using Lipofectamine 2000
transfection reagent (Thermo Fisher Scientific; 12566014).
Briefly, for each well, 3,000 HeLa–ss-HRP cells in 80 µl of
complete medium lacking penicillin/streptomycin were plated
into a 96-well plate containing 20 µl of 250 nM siRNA and 0.5%
(vol/vol) Lipofectamine 2000 in OptiMEM (Thermo Fisher
Scientific; 319885062). Medium was replaced after 24 h. After
two additional days, cells were washed with medium and in-
cubated with 150 µl of complete medium for 8 h. Then 50 µl of
the medium was collected and mixed with ECL reagent (GE
Healthcare; RPN2106) in white CulturPlate 96-well plates (Per-
kinElmer; 6005680), and the chemiluminescence was measured
in a Tecan Microplate reader M1000 PRO. For normalization,
cells were lysed with lysis buffer supplemented with protease
inhibitors to quantify intracellular HRP activity.
Flow cytometry
After CRISPRi- or siRNA-mediated target gene knockdown, cells
were washed with PBS and detached by incubation with 0.5 mM
EDTA in PBS for 10 min. Cells were then resuspended in
blocking buffer (OptiMEM containing 5% FBS), and live cells
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were incubated for 1 h at 4°C with an anti-TAC antibody con-
jugated to PE. GFP and PE fluorescence were collected on a LSR
Fortessa (BD Biosciences) and analyzed using FlowJo software
(FlowJo). For surface MHC-I expression, cells were washed with
PBS and detached by incubation with 0.5 mM EDTA in PBS for
10 min. Cells were then fixed with 4% (wt/vol) PFA in PBS for
15 min at room temperature, washed, and incubated for 1 h at
4°Cwith an anti–MHC-I antibody. The epitope recognized by the
anti–MHC-I antibody localizes in the extracellular domain of
MHC-I. Cells were washed again, incubated with a goat anti-
mouse IgG–Alexa Fluor 488 and fluorescent signals collected
on a LSR Fortessa (BD Biosciences) and analyzed using FlowJo
software (FlowJo). For Tf internalization and recycling, see
section FACS-based endocytosis and recycling assays.
FACS-based endocytosis and recycling assays
Control HeLa cells and cells knocked down for TTC17 and
CCDC157 were detached with 0.5 mM EDTA for 10 min, washed
in serum-free medium, and incubated at 4°C for 30 min in the
presence of 50 µg/ml Tf conjugated with Alexa Fluor 647
(Thermo Fisher Scientific; T23366). Cells were then incubated at
37°C and at different type points (0, 2, 5, 10, and 15 min), Tf in-
ternalization was stopped by placing cells on ice for 10 min. Cells
were then fixed with 4% (wt/vol) PFA in PBS for 15 min at room
temperature and analyzed by flow cytometry on a LSR Fortessa
(BD Biosciences). For recycling assay, cells were incubated with
50 µg/ml Tf conjugated with Alexa Fluor 647 for 30 min at 37°C,
washed, and incubated at 37°C with 100 µg/ml unlabeled Tf for
different time points (0, 5, 10, 15, and 30 min). Cells were then
fixed with 4% PFA and analyzed by flow cytometry.
Immunoblot
Cells were lysed for 30 min on ice in lysis buffer (50 mM Tris,
pH 7.4, 150 mM NaCl, 0.1% SDS, 1% (vol/vol) Triton X-100, and
0.5% sodium deoxycholate) supplemented with protease inhib-
itor cocktail (Sigma-Aldrich; 05892953001), 1 mM Na3VO4, and
25 mM sodium fluoride and centrifuged at 16,000 × g for 15 min.
Samples were incubated with 1× SDS sample buffer at 95°C for
10 min, resolved by 12% SDS-PAGE, and transferred to methanol
activated Immobilon-P 0.45 µm polyvinylidene difluoride
membranes for blotting. Membranes were blocked with 5% (wt/
vol) BSA in PBS containing 0.1% Tween 20 (PBS-T) for 30min at
room temperature and probed with appropriate primary anti-
bodies overnight at 4°C in PBS-T containing 5% (wt/vol) BSA.
Membranes were then washed 3 × 15 min in PBS-T and incu-
bated with the corresponding HRP-conjugated secondary anti-
body for 1 h at room temperature in PBS-T containing 5% (wt/
vol) BSA. Membranes were then washed again for 3 × 15 min in
PBS-T, and signals were detected with ECL Western Blotting
Detection Reagent (GE Healthcare; RPN2106) and acquired with
the Chemidoc MP Imaging System (Bio-Rad). Membranes were
stripped with Restore Plus (Thermo Fisher Scientific; 46430)
according to the manufacturer’s instructions.
Immunofluorescence microscopy
Cells grown on coverslips were fixed with cold methanol for
10 min at −20°C or 4% (wt/vol) PFA in PBS for 15 min at room
temperature. Cells fixed with PFA were permeabilized with 0.1%
Triton X-100 in PBS at room temperature and then incubated
with blocking buffer (2.5% [wt/vol] FCS and 0.1% Triton X-100
in PBS) for 30 min at room temperature. Cells were then incu-
bated with primary antibody diluted in blocking buffer for 1 h at
room temperature followed by PBS wash and incubated with
secondary antibody. Secondary antibodies conjugated with
Alexa Fluor 488, 568, or 647 were diluted in blocking buffer and
incubated 1 h at room temperature. Samples were mounted
using ProLong Gold antifade reagent with DAPI (Thermo Fisher
Scientific; P36935). Images were acquired with a Leica SP8 laser
confocal scanning microscope with a 40× objective. Images
displayed in figures are representative single Z-slices. After
acquisition, images were processed using an Airyscan process-
ing tool on the ZEN software provided by Zeiss.
For cytosol washout prior to immunofluorescence micros-
copy, cells were washed twice with room temperature KHM
buffer (125 mM potassium acetate, 25 mM Hepes-KOH, pH 7.2,
and 2.5 mMmagnesium acetate). Cells were then permeabilized
by incubation in KHM buffer containing 30 µg/ml digitonin for
5 min on ice followed by a wash for 5 min at room temperature
with KHM buffer. Cells were subsequently fixed with 4% PFA
and processed for immunofluorescence microscopy. This pro-
cedure allows the removal of soluble cytoplasmic pool of pro-
teins, highlighting their potential association with intracellular
compartments.
The level of colocalization was determined by acquiring
confocal images from ∼30 cells per condition. Colocalization
quantifications were performed using Coste’s method of
thresholding with object Pearson’s analysis using Imaris 8.2.0 by
Bitplane AG. Intensity profile graphs of the confocal images
were calculated by a pixel-based method by ImageJ (National
Institutes of Health).
For unbiased analysis of Golgi membrane surface area, im-
ages were analyzed with the CellProfiler software (Broad Insti-
tute; Dao et al., 2016). For each image analyzed, the area of Golgi
membranes, identified as object, was extracted using the module
“MeasureObjectSizeShape.” For unbiased analysis of Golgi
membrane morphology, the classifier of the CellProfiler Analyst
was trained using cells randomly chosen from the whole ex-
periment. These were classified as having a ring shape structure,
fragmented, or intact Golgi. The classifier of the CellProfiler
Analyst was then used to define, for all cells, Golgi membrane
morphology on object level.
In all experiments, images shown in individual panels were
acquired using identical exposure times and scan setting and
adjusted identically for brightness and contrast using Photoshop
CS5 (Adobe).
Transmission electron microscopy
3 d after transfection with individual specific siRNA, control
HeLa cells and cells knocked down for TTC17 and CCDC157 were
fixed with 2% PFA–2% glutaraldehyde solution in sodium caco-
dylate buffer for 1 h at room temperature. Cells were carefully
detached using a plastic cell scraper, collected into Eppendorf
tubes and centrifuged to obtain the pellet. Cells were then post-
fixed for 30 min in 1% OsO4 at room temperature, washed three
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Identification of new factors for secretion https://doi.org/10.1083/jcb.201902028
times in distilled water and post-fixed for 1 h in 1% uranyl ace-
tate. The pellets were dehydrated in graded steps of ethanol (50,
70, 90, 96, and 100%), two times in 100% of propylene oxide, and
embedded into epon. Sections (60 nm thick) were cut on a Leica
UC7 ultramicrotome and examined with a Fei Tecnai 12 BioTwin
Spirit transmission electron microscope.
RT-PCR
Total RNA was extracted from HeLa cells using the RNAeasy
Plus Mini kit (QIAGEN; 74134), and cDNAs were synthesized
with the Cloned AMV First-Strand cDNA Synthesis kit (In-
vitrogen; 12328032) and oligo d(T)20 according to the manu-
facturer’s instruction. cDNA of indicated genes was amplified by
PCR using Q5 HF DNA polymerase (NEB; M0491L) and the fol-
lowing specific primers: GAPDH forward primer 59-ACCACC
ATGGAGAAGGCTGG-39, reverse primer 59-CTCAGTGTAGCC
CAGGATGC-39, PCR product size: 527 bp; SCFD1 forward primer
59-GGGGAAGATGAAGGAGCCATA-39, reverse primer 59-TCA
GCCTCAGAAGGTGCTTG-39, PCR product size: 319 bp; Sec24A
forward primer 59-CCATTGTCCTCGTGCATCAT-39, reverse
primer 59-TGCCAATAAGCCACCTCCTT-39, PCR product size:
369 bp; Sec61A forward primer 59-AGTGGACCTGCCAATCAA
GT-39, reverse primer 59-CTTTGGCAGAGGAACCTGAG-39, PCR
product size: 379 bp; TTC17 forward primer 59-CAGATGACCATG
CACGAAAAA-39, reverse primer 59-GTTGGCCAAGTTGACAAG
AGG-39, PCR product size: 248 bp; CCDC157 forward primer 59-
GCAGCCCACCCACTGTAATAA-39, reverse primer 59-TGCCCT
GGGTGTACTCTCCTA-39, PCR product size: 236 bp; C10orf88
forward primer 59-TACACAACTGCCTGGTGGAGA-39, reverse
primer 59-CGGTCTTATTTCCCACATGGA-39, PCR product size:
218 bp; and CCDC151 forward primer 59-TGAACCAAGAGGCCC
TCAAT-39, reverse primer 59-GCGCTCGTTCTCCAGTTTCT-39,
PCR product size: 148 bp. The PCR products were resolved on
1.5% agarose gel.
Statistical analysis
The statistical details of all experiments are indicated in the
figure legends, including statistical analysis performed, error
bars, statistical significance, and experiment numbers (n). Sta-
tistics were performed using GraphPad Prism 6 software.
Online supplemental material
Fig. S1 shows the establishment of the cell line expressing a dual
fluorescent reporter for protein transport based on the TAC-GFP
expression, and the optimization of experimental conditions to
assess TAC surface expression by flow cytometry. Fig. S2 shows
the ER exit site and ER organization in control cells and in
TTC17- and CCD157-depleted cells visualized by immunofluo-
rescence microscopy. Fig. S3 shows the effect of TTC17 and
CCDC157 knockdown on EEA1 distribution visualized by im-
munofluorescence microscopy. Fig. S4 shows the effect of TTC17
and CCDC157 knockdown on the uptake and recycling of Tf
analyzed by flow cytometry. Table S1 showsMAGeCK analysis of
the pooled genome-wide CRISPRi screen replicate. Table S2
shows the 62 candidate genes selected from the CRISPRi screen
and results of the secondary screen using a secretion assay based
on the detection of ss-HRP by chemiluminescence.
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